Faktor Risiko Kejadian Hepatitis B Pada Ibu Hamil di Kabupaten Luwu Timur

Risk Factors for Hepatitis B Incidence in Pregnant Women in East Luwu District

  • Margaretha Pither Program Pascasarjanan Sekolah Tinggi Ilmu Kesehatan Tamalatea, Makassar
  • Andi Yusuf Program Pascasarjanan Sekolah Tinggi Ilmu Kesehatan Tamalatea, Makassar
  • Rahmawati Aziz Program Pascasarjanan Sekolah Tinggi Ilmu Kesehatan Tamalatea, Makassar
DOI: https://doi.org/10.56338/mppki.v4i3.1629
Keywords: Faktor risiko, hepatitis B, ibu hamil

Abstract

Latar Belakang: Infeksi hepatitis B (HBV) pada ibu hamil telah menjadi perhatian dunia karena penularan yang paling sering terjadi di seluruh dunia, terutama pada daerah-daerah endemis, yaitu penularan dari ibu ke anak pada masa prepartum atau perinatal dengan risiko tertular infeksi hepatitis B (HBV) pada anak lebih dari 90%.

Metode: Penelitian ini merupakan penelitian kuantitatif menggunakan metode analitik observasional dengan desain case control study. Populasi dalam penelitian ini yaitu seluruh ibu hamil yang mengikuti layanan Antenatal Care selama periode Januari – Maret 2021 di fasilitas kesehatan Kabupaten Luwu Timur. Penentuan besar sampel dengan cara “Total Sampling†untuk kelompok kasus yaitu sebanyak 50 responden dengan perbandingan kelompok kasus dan kelompok kontrol yaitu 1 : 1. Pemeriksaan HbsAg menggunakan alat Rapid Diagnostic Test (RDT). Data yang diperoleh, diolah dan dianalisis secara bivariat dengan uji chi-square dan analisis multivariat dengan uji regresi logistik menggunakan Aplikasi SPSS.

Hasil: Uji statistik menunjukkan bahwa tingkat pendidikan (p-value = 0,027; OR = 2,705; IK 95%: 1,197-6,113), paritas (p-value = 0,023; OR = 2,846; IK 95%: 1,228-6,697), dan pasangan seksual (p-value = 0,031; OR = 9,333; IK 95%: 1,121-77,704) merupakan faktor risiko kejadian hepatitis B pada ibu hamil. Sedangkan kelompok umur (p-value = 0,177) dan jenis pekerjaan (p-value = 0,059) tidak menjadi faktor risiko kejadian hepatitis B pada ibu hamil.

Kesimpulan: Tingkat pendidikan, paritas, dan pasangan seksual merupakan faktor risiko kejadian hepatitis B pada ibu hamil. Diantara semua faktor risiko yang ditemukan, pasangan seksual merupakan faktor yang paling berisiko terhadap kejadian hepatitis B pada ibu hamil di Kabupaten Luwu Timur tahun 2021 (p-value = 0,022; OR: 12,920; IK 95%: 1,440-115,894)

References

1. Abongwa LE, Kenneth P, Bamenda B. Assessing Prevalence and Risk Factors of Hepatitis B Surface. Eur J Res Med Sci. 2016;4(1):32–43.
2. Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission. J Pregnancy. 2018;2018:1–9.
3. Umare A, Seyoum B, Gobena T, Mariyam TH. Hepatitis B virus infections and associated factors among pregnant women attending antenatal care clinic at deder hospital, eastern Ethiopia. PLoS One. 2016;11(11):1–11.
4. Dinkes.Lutim. Hepatitis B pada Ibu Hamil di Kabupaten Luwu Timur. Malili; 2021.
5. Badfar G, Shohani M, Nasirkandy MP, Mansouri A, Abangah G, Rahmati S, et al. Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis. Arch Virol. 2018;163(2):319–30.
6. Balitbangkes. Situasi dan Analisis Hepatitis di Indonesia. Pusat data dan informasi Kementrian kesehatan RI. Jakarta: Kementerian Kesehatan Republik Indonesia; 2014. p. 1–8.
7. WHO. Prevention of Mother-to-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy [Internet]. Prevention of Mother-to-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy. 2020. 1–58 p. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32833415
8. Sinaga H, Latif I, Pangulu N. Pemeriksaan Hepatitis B Surface Antigen (HBsAg) dan Anti-HBs Pada Ibu Hamil Sebagai Skrining Penularan Hepatitis B. J Ris Kesehat. 2018;7(2):81–4.
9. Anaedobe CG, Fowotade A, Omoruyi CE, Bakare RA. Prevalence, socio-demographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. Pan Afr Med J. 2015;20(406):1–11.
10. Azami M, Khataee M, Beigom Bigdeli Shamloo M, Abbasalizadeh F, Rahmati S, Abbasalizadeh S, et al. Prevalence and Risk factors of hepatitis B Infection in pregnant women of Iran: a systematic review and meta-analysis. Iran J Obstet Gynecol Infertil. 2016;19(18):17–30.
11. Ngaira JAM, Kimotho J, Mirigi I, Osman S. Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan Afr Med J. 2016;24(315).
12. Siwi YAPE, Prijatni I, Sutrisno. Analisis Karakteristik Ibu Hamil dengan HbsAg Positif di RSUD dr. H. Koesnadi Bondowoso. Malang J Midwifery. 2020;2(1):146–54.
13. Umare A, Seyoum B, Gobena T, Haile Mariyam T. Hepatitis B virus infections and associated factors among pregnant women attending antenatal care clinic at Deder Hospital, Eastern Ethiopia. PLoS One. 2016;11(11):e0166936.
14. Metaferia Y, Dessie W, Ali I, Amsalu A. Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study. Epidemiol Health. 2016;38(e2016027).
15. Molla S, Munshea A, Nibret E. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of Felege Hiwot Referral Hospital, northwest Ethiopia: a cross-sectional study. Virol J. 2015;12(1):1–9.
16. Kebede KM, Abateneh DD, Belay AS. Hepatitis B virus infection among pregnant women in Ethiopia: A systematic review and Meta-analysis of prevalence studies. BMC Infect Dis. 2018;18(1):1–9.
17. Hang Pham TT, Le TX, Nguyen DT, Luu CM, Truong BD, Tran PD, et al. Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam. PLoS One. 2019;14(4):1–15.
18. WHO. World Hepatitis Day 2019 Invest in Eliminating Hepatitis. France; 2019.
19. Manyahi J, Msigwa Y, Mhimbira F, Majigo M. High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: A cross sectional study. BMC Pregnancy Childbirth. 2017;17(1):1–6.
20. Tanga AT, Teshome MA, Hiko D, Fikru C, Jilo GK. Sero-prevalence of hepatitis B virus and associated factors among pregnant women in Gambella hospital, South Western Ethiopia: facility based cross-sectional study. BMC Infect Dis. 2019;19(1):1–7.
21. Magaji FA, Okolo MO, Hassan Z, Shambe IH, Pam VC, Ocheke AN, et al. Prevalence of hepatitis B virus infection among pregnant women in Jos, Nigeria. Ann Afr Med. 2020;19(3):176.
22. Liu J, Liu J, Liu M, Pang Q, Wen Y. Prevalence of hepatitis B virus infection and its associated factors among 15,461 pregnant women in Yunnan province, China. Ann Epidemiol. 2020;49:13–9.
23. Rumini, Zein U, Suroyo RB. Risk Factors Of Hepatitis B In Patient In The Dr. Pirngadi Hospital Medan. J Kesehat Glob. 2018;1(1):37–74.
24. Cetin S, Cetin M, Turhan E, Dolapcioglu K. Seroprevalence of hepatitis B surface antigen and associated risk factors among pregnant women. J Infect Dev Ctries. 2018;12(10):904–9.
25. Nguyen AT Le, Le XTT, Do TTT, Nguyen CT, Hoang Nguyen L, Tran BX, et al. Knowledge, Preference, and Willingness to Pay for Hepatitis B Vaccination Services among Woman of Reproductive Age in Vietnam. Biomed Res Int. 2019;2019.
Published
2021-09-08
How to Cite
Pither, M., Yusuf, A., & Aziz, R. (2021). Faktor Risiko Kejadian Hepatitis B Pada Ibu Hamil di Kabupaten Luwu Timur: Risk Factors for Hepatitis B Incidence in Pregnant Women in East Luwu District. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 4(3), 432-438. https://doi.org/10.56338/mppki.v4i3.1629
Issue
Vol. 4 No. 3: SEPTEMBER 2021 - Media Publikasi Promosi Kesehatan Indonesia (MPPKI)
Section
Research Article

Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:

  1. Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.

  2. Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.

  3. License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.